Last reviewed · How we verify
NCT05694104: CNFD 2020
China Nutrition Fundamental Data 2020
trial testing Malnutrition in Nutritional Status of Chinese Inpatients;Nutritional Service Capacity of Medical Institutions in China in 54,677 participants. Completed in 7 January 2022.
2 August 2021
Quick facts
| Lead sponsor | Peking Union Medical College Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 54,677 |
| Start date | 24 August 2020 |
| Primary completion | 2 August 2021 |
| Estimated completion | 7 January 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Malnutrition
Conditions studied
- Nutritional Status of Chinese Inpatients;Nutritional Service Capacity of Medical Institutions in China — all drugs for Nutritional Status of Chinese Inpatients;Nutritional Service Capacity of Medical Institutions in China →
Sponsor
Peking Union Medical College Hospital
Who can join
18 and older, any sex, with Nutritional Status of Chinese Inpatients;Nutritional Service Capacity of Medical Institutions in China. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Malnutrition caused by reduced food intake or assimilation and varying degrees of acute or chronic inflammation is a serious and underappreciated risk factor for adverse clinical outcomes. Despite the substantial health and economic burden, malnutrition remains to affect a considerable proportion of hospitalized patients worldwide. Nationally representative studies from the USA, Australia, and European countries have reported prevalence figures in the range of 8.9% to 80.4%. However, national data in some resource-poor countries, such as China, the largest developing country in the world, are scarce. We did the China Nutrition Fundamental Data 2020 in a large, nationally representative sample of Chinese adult inpatients to 1) Explore the relationship between nutrition and health; 2) Understand the capacity of nutrition services in Chinese medical institutions. This project adopted a multistage, stratified, cluster-sampling procedure based on administrative divisions in China. For each participant, a structured interview was done by trained nutritionists or clinicians. The following data were acquired: weight change within and beyond six months, food intake change within two weeks, nutrition therapy during this hospitalization, and laboratory tests. We also collected information on participants' sociodemographic characteristics and medical history. We took physical measurements, including height, weight, waist circumference, hip circumference, mid-arm circumference, calf circumference, handgrip strength, and blood pressure following standard protocols. Body composition was measured using bioimpedance analysis (BIA). In total, 54677 inpatients from 291 project hospitals completed information collection. In addition, we collected information on the number of beds, the nutrition support team, the nutrition treatment plan and the construction of a full-time nutrition physician or nutrition nurse, the routine monitoring methods, interventions, and distribution of brochures for patients with malnutrition or nutritional risk in each project hospital and 37 other hospitals based on the principle of voluntary participation. A total of 328 hospitals completed information collection. This project will establish standards for nutrition risk assessment, diagnosis, and treatment of inpatients in China, promote the construction of clinical nutrition departments, and improve the nutritional status of inpatients.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Nutritional status and nutritional intervention of older inpatients in China.
Qing H, Zhang XD, Yang E, Li HX, et al · · 2024 · cited 3× · PMID 38308922 · DOI 10.1016/j.jnha.2024.100169 -
Prevalence of borderline elevated and elevated cholesterol among new adult patients from 23 hospitals in 12 cities of Jiangsu Province: a multicenter cross-sectional study.
Zhang W, Tang K, Zhou L, Ma X, et al · · 2026 · PMID 41994088 · DOI 10.3389/fnut.2026.1800853 -
Prevalence of malnutrition and appropriateness of nutritional support in hospitalized patients: a GLIM-based study.
Deng LM, Liu SP, Long JF, Mo H, et al · · 2025 · PMID 41141257 · DOI 10.3389/fnut.2025.1667821
Verify or expand the search:
- PubMed search for NCT05694104
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Malnutrition
Trials testing the same drug.
- NCT05705882 — China Nutrition Fundamental Data 2022 · unknown
Other Peking Union Medical College Hospital trials
Trials by the same sponsor.
- NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
- NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
- NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
- NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
- NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05694104 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
- Last refreshed: 23 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05694104.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing